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cense.Abstract Synthesis and characterization of molybdenum complex with tolbutamide (an oral anti-
diabetic drug) have been studied. The conductometric titration using monovariation method indi-
cates that complex is non-ionic and of L2M type. Analytical data agree with the molecular formula
(C12H17N2O3S)2MoÆ2H2O. Structure of the complex was assigned as octahedral in which ligand
molecules lie horizontally joining the central molybdenum atom and one water molecule, each
attached vertically with the metal. Infra-red spectral studies conﬁrm the coordination of sulphonyl
oxygen on one side and enolic oxygen attached from other side with the metal ion. IR and 1H NMR
studies support structure II proposed on the basis of analytical data. Magnetic susceptibility data
suggested that the complex is diamagnetic. Thermal studies support the presence of ligand moieties
and coordinated water. X-ray diffraction data also support the complex formation.
ª 2010 King Saud University.Open access under CC BY-NC-ND license.1. Introduction
Metal ions are required for many critical functions in human.
Scarcity of some metal ions can lead to disease. Well-known
examples include pernicious anemia resulting from iron deﬁ-S.A. Iqbal), ishaq_zaafarany@
ity.
lsevierciency, growth retardation arising from insufﬁcient dietary
zinc, and heart disease in infants owing to copper deﬁciency.
The ability to recognize, to understand at the molecular level,
and to treat the diseases caused by inadequate metal-ion func-
tion constitutes an important aspect of medicinal bioinorganic
chemistry. Understanding the biochemistry and molecular
biology of natural detoxiﬁcation mechanisms and designing
and applying ion-speciﬁc chelating agents to treat metal over-
loads are the two components of a second major aspect of the
new science that is evolving at the interface of bioinorganic
chemistry and medicine.
Diabetes is a deceptive disease and if not detected in early
stage may cause even death. It is considered hereditary but ac-
tual genetic disorder is still a mystery. Several million peoples
are suffering from this disease all over the world (Sadilot and
Phatak, 1992; Bloomgarden, 1999; Sanger and Thompson,
346 S.A. Iqbal et al.1953). Zinc-insulin was discovered as early as in 1921 and later
it proved to be a very efﬁcacious medicine in the treatment of
diabetes mellitus. To avoid the daily pricks of hypodermic syr-
inge, oral hypoglycemic agents were discovered which has rev-
olutionized the treatment of diabetes. It is worth while to
mention here that the majority of the essential metallic ele-
ments of biological importance are transition metals, whose
ability to from coordination complexes and chelates is the
characteristic aspect of their chemistry.
In recent years much attention is given to the use of sulpho-
nylureas because of their high complexing nature with essential
metals. Sulphonylureas are effective for non-insulin dependent
diabetes mellitus (Sadilot and Phatak, 1992; Bloomgarden,
1999; Sanger and Thompson, 1953). These compounds are
completely absorbed on oral administration. They are metab-
olized by liver and are excreted predominantly through urine.
Complexation of sulphonylureas with lighter transition
metals has been studied in detail by Yoshinaga and Yamamotto
(1966a,b), Iqbal (1984, 1986), Iqbal et al. (1985), Iqbal and
Desnavi (1989), and Qureshi and Iqbal (1987a,b). A perusal of
available literature shows that systemic study on complexation
of molybdenum with sulphonylureas is relatively scanty. The
study of chemistry and chemical reaction of coordination com-
pound help in establishing structure–activity relationship. It has
been reported that in biological activity metal complex is more
potent and less toxic as compared to the free ligand (Singel,
1982; Brown, 1982; Phipps, 1976; Williams, 1976; Lippard,
1983; Meares and Wensel, 1984). In view of the above and in
continuation of our work, it is interesting to have an insight into
the synthesis of molybdenum complex with tolbutamide and to
diagnose various structural aspects of the isolated complex.
Here the synthesis and characterization of molybdenum
complex with tolbutamide have been described (Coughlan,
1980; Hinton and Dean, 1990; Sitefel, 1977).Table 1 Tolbutamide with molybdenum trioxide (Job’s method).
Mole metal ligand ratio Conductance · 104 mhos C
M:S C1 S:L C2 M:L C3 C
0:12 0.08 4.60 4.60 0.
1:11 0.78 4.31 4.84 0.
2:10 1.46 4.07 5.10 0.
3:9 2.10 3.83 5.36 0.
4:8 2.74 3.59 5.58 0.
5:7 3.28 3.25 5.90 0.
6:6 3.92 3.01 6.34 0.
7:5 4.61 2.62 6.75 0.
8:4 5.15 2.28 7.03 0.
9:3 5.79 1.89 7.33 0.
10:2 6.38 1.42 7.56 0.
11:1 7.07 1.06 7.95 0.
12:0 7.76 0.73 8.39 0.
Tolbutamide 0.005 M; MoO3 0.005 M.
Solvent 80% ethanol; temperature 27 C.
M=metal solution, L = ligand solution, S = solvent.
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Tolbutamide (I)2. Experimental
2.1. Ligand–metal ratio
(a) Pure tolbutamide (I) m.p. 129 C (Lit. 128.5–129.5)
0.005 M and molybdenum trioxide 0.01 M (Analar
grade) were prepared in puriﬁed 80% ethanol. Tolbuta-
mide (20 mL) was diluted to 200 mL and titrated con-
ductometrically against molybdenum trioxide at
27 ± 1 C. Results were plotted in the form of a graph
which indicates ligand–metal ratio as 2:1.
(b) Formation of 2:1 (L2:M) ratio was also conﬁrmed by
Job’s method of continuous variation as modiﬁed by
Turner and Anderson, using D conductance as index
property. From these values the stability constant (log k)
and free energy change (DF) were also calculated
(Irving and Rossotti, 1954, 1953, 1955; Willard et al.,
0000) (Tables 1 and 2; Fig. 1).
2.2. Synthesis of complex
The chemicals used in this synthesis were all of analytical
grade. A weighed quantity of tolbutamide (2 mol) was dis-
solved in minimum quantity of 80% ethanol. The molybde-
num solution was prepared by dissolving it separately in the
same solvent. Ligand solution was added slowly with stirring
into the solution of metallic salt at room temperature main-
taining the pH between 6 and 6.5 by adding dilute NaOH solu-
tion. On reﬂuxing the mixture for 3 h and on cooling, the
complex separated out, which was ﬁltered off, washed well
with ethanol and ﬁnally dried in vacuum and weighed.
The elemental analyses of the isolated complex were carried
out using the reported methods (Jeffery et al., 1989; Moham-
med, 1989; Scott, 1960) (Table 3). Molybdenum was estimated
as lead molybdate. The IR spectrum of the ligand as well as of
the complex was recorded on B. OMEM–FTIR (USA), 1H
NMR spectra of the ligand and isolated complex were re-
corded on a Bruker AM-200 spectrometer, and d6-DMSO
was used as a solvent (Table 4).onductance · 104 mhos Corrected D conductance · 104 mhos
1 + C2  C3
08 0.00
25 0.17
43 0.34
57 0.47
75 0.64
65 0.55
59 0.50
48 0.40
40 0.33
35 0.27
24 0.18
18 0.10
10 0.00
Table 2 Tolbutamide with molybdenum trioxide (Job’s method).
Mole metal ligand ratio Conductance · 104 mhos Conductance · 104 mhos Corrected D conductance · 104 mhos
M:S C1 S:L C2 M:L C3 C1 + C2  C3
0:12 0.04 3.65 3.65 0.04 0.00
1:11 0.61 3.39 3.86 0.14 0.10
2:10 1.22 3.15 4.07 0.30 0.25
3:9 1.77 2.94 4.26 0.45 0.40
4:8 2.30 2.73 4.47 0.56 0.52
5:7 2.84 2.37 4.71 0.50 0.45
6:6 3.38 2.00 4.96 0.42 0.38
7:5 3.79 1.76 5.21 0.34 0.30
8:4 4.30 1.47 5.8 0.29 0.24
9:3 4.76 1.14 5.69 0.21 0.15
10:2 5.20 0.85 5.91 0.14 0.10
11:1 5.64 0.60 6.17 0.07 0.03
12:0 6.10 0.34 6.39 0.05 0.00
Tolbutamide 0.002 M; MoO3 0.002 M.
Solvent 80% ethanol; temperature 27 C.
M=metal solution, L = ligand solution, S = solvent.
Synthesis and characterization of tolbutamide–molybdenum complex by thermal, spectral and X-ray studies 347For the thermal studies, Differential Scanning Calorimetry
(DSC) technique was adopted. The DSC measurements were
carried out on a TA instrument 2000 (USA) Houte and Sayed
Ali, 1991; Mackenzie, 1984; Szabadvary and Buzah Ghee,
1979; Agrawal et al., 2003; Patel et al., 2001.Figure 1 Tolbutamide molbdenum trioxide. Jobs method.X-ray diffractometer model Rigaku D-max/B, with 12 kW
Rotating Anode X-ray generator was used for scanning the li-
gand, metal salt and respective complex. Radiation used was
Cu Ka (1 W= 1.5418 A˚). The samples were scanned in the
range 10–70. Powder data were indexed using computer
software.
From stoichiometry and analytical data, the composition of
the complex comes out to be (C12H17N2O3S)2MoÆ2H2O, which
favours 2:1 (L:M) ratio. The tentative structure (II) assigned to
the complex on the basis of analytical data is further supported
by Differential Scanning Calorimetry (DSC), XRD and spectral
data (Cullity, 1978; Bragg and Bragg, 1993; Guinier, 1952;
Cullity, 1978; Jenkins and Devries, 1970; Henry et al., 1951).
3. Results and discussion
The thermal studies using DSC method conﬁrm that the
complex obtained is a well knit one with water of hydration.
It has a sharp melting peak indicating that the entire process
of melting took place in a short temperature range 124–
130 C. It is also devoid of water of hydration and hence the
structure looses its crystallinity and water of coordination
and gets melted simultaneously. Molybdenum is highly elec-
tropositive and hence the complex melts at higher temperature
of 128 C. The magnetic studies indicate that the complex is
diamagnetic in nature (Fig. 2).
Other features of NMR spectrum were the aromatic proton
resonances located and the presence of unresolved multiplet,
suggestive of excessive deshielding of aromatic protons (Akitt,
1973; Slichter, 1963; Siewers, 1973; Patel et al., 2001; Sayeed
et al., 2003; Patel et al., 2001).
The IR spectra of the ligand and the isolated complex were
scanned within the range 4000–400 cm1. The assignments of
the infra-red spectral bands are based on the literature (Table 5;
Fig. 3).
A strong band in the region of 3334 cm1 indicates the pres-
ence of co-coordinated water which was further conﬁrmed by
thermal studies.
The proposed structure for the isolated complex is also sup-
ported by IR absorption bands (Weissberger, 1956; Cotton,
Table 3 The 1H NMR spectra of the ligand and its molybdenum complex displayed a complex pattern.
For tolbutamide For tolbutamide–molybdenum complex
1H NMR (200 MHz, CDCl3)
1H NMR (200 MHz d6-DMSO)
10.08 (bs, 1H, –SO2NH), 7.76 (d, 2H, J= 8 Hz) 10.04 (6s, H–SO2NH), 7.70 (d, 2H, J= 8 Hz)
7.21 (d, 2H, J= 8 Hz), 5.98 (t, 1H–NH–CH2, J= 6 Hz) 7.18 (d, 2H, J= 8 Hz), 6.07 (9s, H–NH–CH2)
2.95 (q, 2H, J= 6 Hz), 2.33 (s, 3H) 2.95 (m, 2H), 2.32 (s, 3H), 1.36–1.05 (m, 4H)
1.37–1.06 (m, 4H), 0.76 (t, 3H, J= 6 Hz) 0.76 (t, 3H, J= 6 Hz)
s = singlet, d = doublet, t = triplet q = quartet, m = multiplet, bs = broad singlet
Table 4 Physico-chemical and analytical data of tolbuta-
mide–molybdenum complex.
Composition of complex (C12H17N2O3S)2MoÆ2H2O
Ligand metal ratio 2:1
Colour Oﬀ white
% Yield 60%
Melting point 128 C
% of metal observed (required) 14.30 (14.32)
% of carbon observed (required) 44.30 (42.98)
% of hydrogen observed (required) 4.95 (5.07)
% of nitrogen observed (required) 7.70 (8.35)
% of sulphur observed (required) 9.21 (9.55)
% of water observed (required) 5.32 (5.37)
Stability constant (log k) 11.53 l/mol
Free energy charge (DF) 15.82 kcal/mol
Figure 2 Differential scanning calorimetry of tolbutamide
molybdenum complex.
Table 5 Speciﬁc IR assignments of tolbutamide and its
molybdenum complex.
IR frequencies (cm1) Assignments
660 ± 5 Metal oxygen bond
875 Aromatic ring vibration
1008 S‚O frequency (LJB/359) (Bellamy, 1964)
1090 C–O of chelate ring
1165 ± 5 SO2N frequency
1400 Six-membered enolic ring structure
modiﬁed in complex
1660 ± 5 C–O stretching frequency (KN/184)
(Nakamotto, 1963)
2500 C‚N stretching frequency
3334 Coordinated water
705 ± 5 Ar–S linkage (LJB/355) (Bellamy, 1964)
840 ± 5 1,4 disubstituted benzene ring frequency
Figure 3 Infra-red spectra of tolbutamide molybdenum
complex.
348 S.A. Iqbal et al.1960; Nakamotto, 1963; Rao, 1963; Bellamy, 1964) obtained at
1160 ± 20 cm1 which is the characteristic of SO2–N group
furthermore, a frequency at 960 cm1 in the complex, charac-
teristic of combination frequency resulting from C‚N stretch-
ing vibration and M–O stretch. Absorption bands due to
C‚N stretching (Jeffery et al., 1989) vibrations are also found
in the region 1660 ± 5 cm1. The complex also displays a
band at 1290 cm1, which is considered to be associated with
m C‚N bond (Table 5).
X-ray diffraction studies also conﬁrm the complexation and
formation of new bands. The number of peaks in tolbutamideis 19 (Table 6) and that of molybdenum trioxide is 10 (Table 7)
while that in the complex is 25 (Table 8). Thus indicating that
the complex formed is a well knit one, moreover the X-ray pat-
tern of neither tolbutamide nor molybdenum trioxide is seen in
the diffractogram of the complex. All the reﬂections present
are new ones and the pattern is fairly strong. The diffracto-
gram of the complex is characterized by an almost complete
lack of periodicity suggesting its amorphous nature. On com-
paring the pattern obtained with the available literature, it be-
came evident that the pattern is not in good agreement with the
available information and thus conﬁrm the formation of a to-
tally new complex (Tables 6–8).
Table 6 X-ray data of (a) tolbutamide and (b) molybdenum
trioxide.
Peak 2h D-space I (CPS)
(a) Tolbutamide
1 8.967 9.8537 2121.0
2 12.312 7.1832 1009.0
3 13.290 6.6567 635.0
4 14.520 6.0955 624.0
5 174.730 4.9985 897.0
6 19.780 4.4848 466.0
7 20.140 4.4055 567.0
8 21.104 4.2064 1451.0
9 23.300 3.8146 440.0
10 24.950 3.5660 293.0
11 26.530 3.3571 379.0
12 26.860 3.3166 227.0
13 28.410 3.1391 265.0
14 29.010 3.0755 426.0
15 30.670 2.9127 244.0
16 33.170 2.6987 246.0
17 35.640 2.5171 297.0
18 38.870 2.3150 208.0
19 43.970 2.0576 122.0
Table 7 X-ray data of molybdenum trioxide.
Peak 2h D-space I (CPS)
1 12.742 6.9419 147
2 23.310 3.8130 615.0
3 25.659 3.4691 1616.0
4 27.280 3.2665 561.0
5 38.930 2.3116 965.0
6 39.560 2.2762 378.0
7 46.270 1.9606 347.0
8 57.730 1.5957 308.0
9 58.820 1.5687 348.0
10 67.520 1.3861 316.0
Table 8 X-ray data of tolbutamide–molybdenum complex.
Peak 2h D-space I (CPS)
1 8.717 10.1356 1173.0
2 10.250 8.6232 606.0
3 11.290 7.8311 520.0
4 12.090 7.3146 772.0
5 13.070 6.7683 568.0
6 14.270 6.2017 567.0
7 15.450 5.7306 514.0
8 17.300 5.1217 392.0
9 17.520 5.0597 462.0
10 19.230 4.6118 352.0
11 19.510 4.5463 536.0
12 19.880 4.4625 473.0
13 20.870 4.2530 654.0
14 23.070 3.8521 392.0
15 24.720 3.5986 252.0
16 25.770 3.4543 294.0
17 26.340 3.3809 357.0
18 28.180 3.1642 267.0
19 28.770 3.1006 359.0
20 30.450 2.9332 234.0
21 33.000 2.7122 187.0
22 35.030 2.5595 196.0
23 35.460 2.5295 202.0
24 36.440 2.4336 163.0
25 43.720 2.0688 150.0
Synthesis and characterization of tolbutamide–molybdenum complex by thermal, spectral and X-ray studies 349Keeping in view all these observations and results, the fol-
lowing structure of tolbutamide–molybdenum complex can be
proposed for the isolated complex.
CH3S
O
O
CN
O
NH
H9C4
OH2H2O
C N C4H9
O
H3C S
O
O
Mo
NH
Tolbutamide-Mo Complex
[Structure (II)]
The structure (II) of the complex is further supported by the
values of 1H NMR as well as IR frequencies (Table 2). More-
over the enolization of N1 nitrogen is not possible because itshydrogen is simultaneously attracted from the group SO2 from
one side and C‚O on the other side, on the other hand the
participation of N2 hydrogen in enolization is supported from
the fact that butyl group is electron releasing while on other
side carbonyl oxygen is proton attracting.
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